The global isoflavones market was valued at $975.0 million in 2020, and is projected to reach $1,707.5 million by 2030, registering a CAGR of 5.8%.
Isoflavones are a type of nutritional supplement that is almost entirely produced by the Fabaceae, Leguminosae, or bean family. It is a specific group of molecules, also known as a phytochemical, which can be found in foods, such as legumes, and herbs such as red clover. Isoflavones have the potential to protect against age-related diseases such as cardiovascular disease, osteoporosis, hormone-dependent cancer, and cognitive decline.
Isoflavones lower the risk of breast cancer while also inhibiting cancer cell growth by reducing cell multiplication. It is also a good source of antioxidants, which help to protect the cardiovascular system by lowering cholesterol levels. It also lowers the risk of stroke and coronary heart disease. As a result of these advantages, the popularity of isoflavones is growing. The increased use of isoflavones in the cosmetics and food & beverage industries is driving the global demand for isoflavones.
However, side effects, such as thyroid disorders, food allergies, migraine headaches, and increased heart rate after excessive consumption, are limiting the growth of the global isoflavones market. Regulations governing the use of isoflavones in nutraceuticals, nutraceutical cosmetics, and dietary supplements, particularly infant formulas, are extremely stringent in some regions and will pose a challenge to the market players.
The pandemic of COVID-19 has raised consumer awareness of the importance of a healthy diet and supplements. Many dietary supplements and nutraceuticals products consist of isoflavones, which help to build gut health. As a result, the isoflavones market was moderately affected due to the pandemic.
Consumption of isoflavones through food and food supplements also reduces the risk of breast cancer and cancer cell growth by reducing cell mitosis, which boosts the demand for isoflavones from the food & beverages industry and has become a driving factor for the global isoflavones market. The cosmetics industry's increasing demand for isoflavones to treat skin wrinkles, protect skin from sun damage, and moisturize skin drives the global isoflavones market.
The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, the market is categorized into soy, red clover, and others. As per application, the market is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, the isoflavones market is fragmented into powder and liquid. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, the Netherlands, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Argentina, Saudi Arabia, and the rest of LAMEA).
Asia-Pacific is witnessing a significant increase in consumer awareness as a result of global players' competitive strategies. Demand from countries, such as India, China, and Australia, is helping to drive the overall growth. The growing population, combined with rising disposable income and living standards, is expected to contribute to the overall growth.
The market is being driven by factors such as rapid growth in the food & beverage industries in developing countries, such as India and China, as well as increased awareness of the benefits of isoflavones products. The major players operating in the global isoflavones market are Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
North America
LAMEA
Isoflavones are a type of nutritional supplement that is almost entirely produced by the Fabaceae, Leguminosae, or bean family. It is a specific group of molecules, also known as a phytochemical, which can be found in foods, such as legumes, and herbs such as red clover. Isoflavones have the potential to protect against age-related diseases such as cardiovascular disease, osteoporosis, hormone-dependent cancer, and cognitive decline.
Isoflavones lower the risk of breast cancer while also inhibiting cancer cell growth by reducing cell multiplication. It is also a good source of antioxidants, which help to protect the cardiovascular system by lowering cholesterol levels. It also lowers the risk of stroke and coronary heart disease. As a result of these advantages, the popularity of isoflavones is growing. The increased use of isoflavones in the cosmetics and food & beverage industries is driving the global demand for isoflavones.
However, side effects, such as thyroid disorders, food allergies, migraine headaches, and increased heart rate after excessive consumption, are limiting the growth of the global isoflavones market. Regulations governing the use of isoflavones in nutraceuticals, nutraceutical cosmetics, and dietary supplements, particularly infant formulas, are extremely stringent in some regions and will pose a challenge to the market players.
The pandemic of COVID-19 has raised consumer awareness of the importance of a healthy diet and supplements. Many dietary supplements and nutraceuticals products consist of isoflavones, which help to build gut health. As a result, the isoflavones market was moderately affected due to the pandemic.
Consumption of isoflavones through food and food supplements also reduces the risk of breast cancer and cancer cell growth by reducing cell mitosis, which boosts the demand for isoflavones from the food & beverages industry and has become a driving factor for the global isoflavones market. The cosmetics industry's increasing demand for isoflavones to treat skin wrinkles, protect skin from sun damage, and moisturize skin drives the global isoflavones market.
The isoflavones market is segmented on the basis of source, application, form, and region. On the basis of source, the market is categorized into soy, red clover, and others. As per application, the market is divided into pharmaceuticals, nutraceuticals, cosmetics, and food & beverages. According to form, the isoflavones market is fragmented into powder and liquid. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, the Netherlands, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Argentina, Saudi Arabia, and the rest of LAMEA).
Asia-Pacific is witnessing a significant increase in consumer awareness as a result of global players' competitive strategies. Demand from countries, such as India, China, and Australia, is helping to drive the overall growth. The growing population, combined with rising disposable income and living standards, is expected to contribute to the overall growth.
The market is being driven by factors such as rapid growth in the food & beverage industries in developing countries, such as India and China, as well as increased awareness of the benefits of isoflavones products. The major players operating in the global isoflavones market are Cargill, Archer-Daniels-Midland (ADM) Company, Badische Anilin und Soda Fabrik (BASF), DSM, International Flavors and Fragrances, Shanghai Freemen, Nexira Inc., Bio-gen Extracts, Sikko Industries, SK Bioland, BioMax, Herbo Nutra, and NutraScience Labs.
KEY BENEFITS FOR STAKEHOLDERS
- The report provides a quantitative analysis of the current market, estimations, trends, and dynamics of the global isoflavones market size from 2020 to 2030 to identify the prevailing market opportunities.
- The key countries in all the major regions are mapped based on the market share and market trends.
- Porter’s five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the market segment and size assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global isoflavones industry.
- Market player positioning segment facilitates benchmarking and provides a clear understanding of the present position of the market players.
KEY MARKET SEGMENTS
By Source
- Soy
- Red Clover
- Others
By Form
- Powder
- Liquid
By Application
- Pharmaceuticals
- Nutraceuticals
- Cosmetics
- Food & Beverages
By Region
North America
- U.S.
- Canada
- Mexico
- UK
- Germany
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Argentina
- Saudi Arabia
- Rest of LAMEA
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY2.1. Snapshot
2.2. Key findings
2.2.1. Top investment pocket
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW3.1. Market definition and scope
3.2. Key forces shaping the global isoflavones market
3.2.1. Bargaining power of suppliers
3.2.2. Bargaining power of buyers
3.2.3. Thereat of new entrants
3.2.4. Threat of substitutes
3.2.5. Intensity of competitive rivalry
3.3. Market dynamics
3.3.1. Drivers
3.3.1.1. Rising prevalence of cancer and cardiovascular diseases
3.3.1.2. Prevalence of menopausal issues
3.3.1.3. Rising demand for fortified food owing to increasing health consciousness amongst consumers
3.3.1.4. Rapidly increasing geriatric population
3.3.2. Restraints
3.3.2.1. Stringent regulatory requirements
3.3.2.2. Less efficiency compared to alternatives
3.3.3. Opportunities
3.3.3.1. Emerging markets
3.3.3.2. Emerging technologies
3.3.4. COVID-19 impact analysis
3.3.5. Player positioning
CHAPTER 4: GLOBAL ISOFLAVONES MARKET, BY SOURCE4.1. Overview
4.1.1. Market size and forecast
4.2. Soy
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Red clover
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Others
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: GLOBAL ISOFLAVONES MARKET, BY APPLICATION5.1. Overview
5.1.1. Market size and forecast
5.2. Pharmaceuticals
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Nutraceuticals
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Cosmetics
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
5.5. Food & beverages
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast
5.5.3. Market analysis, by country
CHAPTER 6: GLOBAL ISOFLAVONES MARKET, BY FORM6.1. Overview
6.1.1. Market size and forecast
6.2. Powder
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast
6.2.3. Market analysis, by country
6.3. Liquid
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast
6.3.3. Market analysis, by country
CHAPTER 7: ISOFLAVONES MARKET, BY REGION7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by source
7.2.3. Market size and forecast, by application
7.2.4. Market size and forecast, by form
7.2.5. Market size and forecast, by country
7.2.6. U.S.
7.2.6.1. Market size and forecast, by source
7.2.6.3. Market size and forecast, by application
7.2.6.4. Market size and forecast, by form
7.2.7. Canada
7.2.7.1. Market size and forecast, by source
7.2.7.3. Market size and forecast, by application
7.2.7.4. Market size and forecast, by form
7.2.8. Mexico
7.2.8.1. Market size and forecast, by source
7.2.8.3. Market size and forecast, by application
7.2.8.4. Market size and forecast, by form
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by source
7.3.3. Market size and forecast, by application
7.3.4. Market size and forecast, by form
7.3.5. Market size and forecast, by country
7.3.6. UK
7.3.6.1. Market size and forecast, by source
7.3.6.3. Market size and forecast, by application
7.3.6.4. Market size and forecast, by form
7.3.7. Germany
7.3.7.1. Market size and forecast, by source
7.3.7.3. Market size and forecast, by application
7.3.7.4. Market size and forecast, by form
7.3.8. France
7.3.8.1. Market size and forecast, by source
7.3.8.3. Market size and forecast, by application
7.3.8.4. Market size and forecast, by form
7.3.9. Italy
7.3.9.1. Market size and forecast, by source
7.3.9.3. Market size and forecast, by application
7.3.9.4. Market size and forecast, by form
7.3.10. Spain
7.3.10.1. Market size and forecast, by source
7.3.10.3. Market size and forecast, by application
7.3.10.4. Market size and forecast, by form
7.3.11. Netherlands
7.3.11.1. Market size and forecast, by source
7.3.11.3. Market size and forecast, by application
7.3.11.4. Market size and forecast, by form
7.3.12. Rest of Europe
7.3.12.1. Market size and forecast, by source
7.3.12.3. Market size and forecast, by application
7.3.12.4. Market size and forecast, by form
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by source
7.4.3. Market size and forecast, by application
7.4.4. Market size and forecast, by form
7.4.5. Market size and forecast, by country
7.4.6. China
7.4.6.1. Market size and forecast, by source
7.4.6.3. Market size and forecast, by application
7.4.6.4. Market size and forecast, by form
7.4.7. Japan
7.4.7.1. Market size and forecast, by source
7.4.7.3. Market size and forecast, by application
7.4.7.4. Market size and forecast, by form
7.4.8. India
7.4.8.1. Market size and forecast, by source
7.4.8.3. Market size and forecast, by application
7.4.8.4. Market size and forecast, by form
7.4.9. South Korea
7.4.9.1. Market size and forecast, by source
7.4.9.3. Market size and forecast, by application
7.4.9.4. Market size and forecast, by form
7.4.10. Australia
7.4.10.1. Market size and forecast, by source
7.4.10.3. Market size and forecast, by application
7.4.10.4. Market size and forecast, by form
7.4.11. Rest of Asia-Pacific
7.4.11.1. Market size and forecast, by source
7.4.11.3. Market size and forecast, by application
7.4.11.4. Market size and forecast, by form
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by source
7.5.3. Market size and forecast, by application
7.5.4. Market size and forecast, by form
7.5.5. Market size and forecast, by country
7.5.6. Brazil
7.5.6.1. Market size and forecast, by source
7.5.6.3. Market size and forecast, by application
7.5.6.4. Market size and forecast, by form
7.5.7. South Africa
7.5.7.1. Market size and forecast, by source
7.5.7.3. Market size and forecast, by application
7.5.7.4. Market size and forecast, by form
7.5.8. Argentina
7.5.8.1. Market size and forecast, by source
7.5.8.3. Market size and forecast, by application
7.5.8.4. Market size and forecast, by form
7.5.9. Saudi Arabia
7.5.9.1. Market size and forecast, by source
7.5.9.3. Market size and forecast, by application
7.5.9.4. Market size and forecast, by form
7.5.10. Rest of LAMEA
7.5.10.1. Market size and forecast, by source
7.5.10.3. Market size and forecast, by application
7.5.10.4. Market size and forecast, by form
CHAPTER 8: COMPETITION LANDSCAPE8.1. Top winning strategies
8.2. Product mapping
8.3. Competitive dashboard
8.4. Competitive heatmap
8.5. Key developments
8.5.1. Acquisition
8.5.2. Business expansion
8.5.3. Joint venture
CHAPTER 9: COMPANY PROFILES9.1. Archer-Daniels-Midland Company (ADM)
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. R&D expenditure
9.1.7. Business performance
9.1.8. Key strategic moves and developments
9.2. BASF SE
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Biomax Life Sciences Limited
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Product portfolio
9.4. Cargill, Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. DSM
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. R&D expenditure
9.5.7. Business performance
9.6. Herbo Nutra
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Product portfolio
9.7. International Flavors and Fragrances
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. R&D expenditure
9.7.7. Business performance
9.7.8. Key strategic moves and developments
9.8. Nexira Inc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Product portfolio
9.9. NutraScience Labs
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments
9.10. Shanghai Freemen
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Product portfolio
List of Tables
TABLE 01. GLOBAL ISOFLAVONES, MARKET BY SOURCE, 2020-2030 ($MILLION)
TABLE 02. SOY ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. RED CLOVER ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. OTHERS ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. GLOBAL ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 06. ISOFLAVONES MARKET FOR PHARMACEUTICALS, BY REGION, 2020-2030 ($MILLION)
TABLE 07. ISOFLAVONES MARKET FOR NUTRACEUTICALS, BY REGION, 2020-2030 ($MILLION)
TABLE 08. ISOFLAVONES MARKET FOR COSMETICS, BY REGION, 2020-2030 ($MILLION)
TABLE 09. ISOFLAVONES MARKET FOR FOOD & BEVERAGES, BY REGION, 2020-2030 ($MILLION)
TABLE 10. GLOBAL ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 11. POWDER ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 12. LIQUID ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. GLOBAL ISOFLAVONES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14. NORTH AMERICA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 15. NORTH AMERICA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16. NORTH AMERICA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 17. NORTH AMERICA ISOFLAVONES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18. U.S. ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 19. U.S. ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20. U.S. ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 21. CANADA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 22. CANADA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 23. CANADA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 24. MEXICO ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 25. MEXICO ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 26. MEXICO ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 27. EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 28. EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 29. EUROPE ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 30. EUROPE ISOFLAVONES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 31. UK ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 32. UK ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33. UK ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 34. GERMANY ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 35. GERMANY ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 36. GERMANY ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 37. FRANCE ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 38. FRANCE ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 39. FRANCE ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 40. ITALY ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 41. ITALY ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42. ITALY ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 43. SPAIN ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 44. SPAIN ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 45. SPAIN ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 46. NETHERLANDS ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 47. NETHERLANDS ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48. NETHERLANDS ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 49. REST OF EUROPE ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 50. REST OF EUROPE ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 51. REST OF EUROPE ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 52. ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 53. ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 55. ASIA-PACIFIC ISOFLAVONES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 56. CHINA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 57. CHINA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 58. CHINA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 59. JAPAN ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 60. JAPAN ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 61. JAPAN ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 62. INDIA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 63. INDIA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 64. INDIA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 65. SOUTH KOREA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 66. SOUTH KOREA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 67. SOUTH KOREA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 68. AUSTRALIA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 69. AUSTRALIA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 70. AUSTRALIA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 73. REST OF ASIA-PACIFIC ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 74. LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 75. LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 76. LAMEA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 77. LAMEA ISOFLAVONES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 78. BRAZIL ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 79. BRAZIL ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 80. BRAZIL ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 81. SOUTH AFRICA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 82. SOUTH AFRICA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 83. SOUTH AFRICA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 84. ARGENTINA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 85. ARGENTINA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 86. ARGENTINA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 87. SAUDI ARABIA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 88. SAUDI ARABIA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 89. SAUDI ARABIA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 90. REST OF LAMEA ISOFLAVONES MARKET, BY SOURCE, 2020-2030 ($MILLION)
TABLE 91. REST OF LAMEA ISOFLAVONES MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 92. REST OF LAMEA ISOFLAVONES MARKET, BY FORM, 2020-2030 ($MILLION)
TABLE 93. ADM: KEY EXECUTIVES
TABLE 94. ADM: COMPANY SNAPSHOT
TABLE 95. ADM: OPERATING SEGMENTS
TABLE 96. ADM: PRODUCT PORTFOLIO
TABLE 97. ADM: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 98. ADM: NET SALES, 2018-2020 ($MILLION)
TABLE 99. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. BASF SE: KEY EXECUTIVES
TABLE 101. BASF SE: COMPANY SNAPSHOT
TABLE 102. BASF SE: OPERATING SEGMENTS
TABLE 103. BASF SE: PRODUCT PORTFOLIO
TABLE 104. BASF SE: NET SALES, 2018-2020 ($MILLION)
TABLE 105. BIOMAX LIFE SCIENCES LIMITED: KEY EXECUTIVES
TABLE 106. BIOMAX LIFE SCIENCES LIMITED: COMPANY SNAPSHOT
TABLE 107. BIOMAX LIFE SCIENCES LIMITED: PRODUCT PORTFOLIO
TABLE 108. CARGILL, INC.: KEY EXECUTIVES
TABLE 109. CARGILL, INC.: COMPANY SNAPSHOT
TABLE 110. CARGILL, INC.: OPERATING SEGMENTS
TABLE 111. CARGILL, INC.: PRODUCT PORTFOLIO
TABLE 112. CARGILL, INC.: NET SALES, 2018-2020 ($MILLION)
TABLE 113. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. DSM: KEY EXECUTIVES
TABLE 115. DSM: COMPANY SNAPSHOT
TABLE 116. DSM: OPERATING SEGMENTS
TABLE 117. DSM: PRODUCT PORTFOLIO
TABLE 118. DSM: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 119. DSM: NET SALES, 2018-2020 ($MILLION)
TABLE 120. HERBO NUTRA: KEY EXECUTIVES
TABLE 121. HERBO NUTRA: COMPANY SNAPSHOT
TABLE 122. HERBO NUTRA: PRODUCT PORTFOLIO
TABLE 123. INTERNATIONAL FLAVORS AND FRAGRANCES: KEY EXECUTIVES
TABLE 124. INTERNATIONAL FLAVORS AND FRAGRANCES: COMPANY SNAPSHOT
TABLE 125. INTERNATIONAL FLAVORS AND FRAGRANCES: OPERATING SEGMENTS
TABLE 126. INTERNATIONAL FLAVORS AND FRAGRANCES: PRODUCT PORTFOLIO
TABLE 127. INTERNATIONAL FLAVORS AND FRAGRANCES: R&D EXPENDITURE, 2018-2020 ($MILLION)
TABLE 128. INTERNATIONAL FLAVORS AND FRAGRANCES: NET SALES, 2018-2020 ($MILLION)
TABLE 129. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 130. NEXIRA INC: KEY EXECUTIVES
TABLE 131. NEXIRA INC: COMPANY SNAPSHOT
TABLE 132. NEXIRA INC: PRODUCT PORTFOLIO
TABLE 133. NUTRASCIENCE LABS: KEY EXECUTIVES
TABLE 134. NUTRASCIENCE LABS: COMPANY SNAPSHOT
TABLE 135. NUTRASCIENCE LABS: PRODUCT PORTFOLIO
TABLE 136. NUTRASCIENCE LABS: NET SALES, 2018-2020 ($MILLION)
TABLE 137. KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 138. SHANGHAI FREEMEN: KEY EXECUTIVES
TABLE 139. SHANGHAI FREEMEN: COMPANY SNAPSHOT
TABLE 140. SHANGHAI FREEMEN: PRODUCT PORTFOLIO
List of FiguresFIGURE 01. KEY MARKET SEGMENTS
FIGURE 02. GLOBAL ISOFLAVONES MARKET
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. HIGH BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTES
FIGURE 08. LOW INTENSITY OF COMPETITIVE RIVALRY
FIGURE 09. GLOBAL ISOFLAVONES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES, 2020-2030
FIGURE 10. GLOBAL ISOFLAVONES MARKET SHARE, BY SOURCE, 2020-2030
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SOY ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF RED CLOVER ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OTHERS ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 14. GLOBAL ISOFLAVONES MARKET SHARE, BY APPLICATION, 2020-2030
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR PHARMACEUTICALS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR NUTRACEUTICALS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR COSMETICS ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ISOFLAVONES MARKET FOR FOOD & BEVERAGES ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 19. GLOBAL ISOFLAVONES MARKET SHARE, BY FORM, 2020-2030
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF POWDER ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIQUID ISOFLAVONES MARKET ($MILLION), BY COUNTRY, 2020 & 2030 (%)
FIGURE 22. GLOBAL ISOFLAVONES MARKET SHARE, BY REGION, 2020-2030
FIGURE 23. U.S. ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 24. CANADA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 25. MEXICO ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 26. UK ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 27. GERMANY ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 28. FRANCE ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 29. ITALY ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 30. SPAIN ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 31. NETHERLANDS ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 32. REST OF EUROPE ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 33. CHINA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 34. JAPAN ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 35. INDIA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 36. SOUTH KOREA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 37. AUSTRALIA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 39. BRAZIL ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 40. SOUTH AFRICA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 41. ARGENTINA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 42. SAUDI ARABIA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 43. REST OF LAMEA ISOFLAVONES MARKET REVENUE, 2020-2030 ($MILLION)
FIGURE 44. TOP WINNING STRATEGIES, BY YEAR, 2018-2021*
FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021* (%)
FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021*
FIGURE 47. PRODUCT MAPPING OF TOP 10 KEY PLAYERS
FIGURE 48. COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
FIGURE 49. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 50. ADM: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 51. ADM: NET SALES, 2018-2020 ($MILLION)
FIGURE 52. ADM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53. ADM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 54. BASF SE: NET SALES, 2018-2020 ($MILLION)
FIGURE 55. BASF SE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56. BASF SE: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57. CARGILL, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 58. CARGILL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 59. DSM: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 60. DSM: NET SALES, 2018-2020 ($MILLION)
FIGURE 61. DSM: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62. DSM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 63. INTERNATIONAL FLAVORS AND FRAGRANCES: R&D EXPENDITURE, 2018-2020 ($MILLION)
FIGURE 64. INTERNATIONAL FLAVORS AND FRAGRANCES: NET SALES, 2018-2020 ($MILLION)
FIGURE 65. INTERNATIONAL FLAVORS AND FRAGRANCES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 66. INTERNATIONAL FLAVORS AND FRAGRANCES: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 67. NUTRASCIENCE LABS: NET SALES, 2018-2020 ($MILLION)
Companies Mentioned
- Cargill
- Archer-Daniels-Midl (ADM) Company
- Badische Anilin und Soda Fabrik (BASF)
- DSM
- International Flavors Fragrances
- Shanghai Freemen
- Nexira Inc.
- Bio-gen Extracts
- Sikko Industries
- SK Biol
- BioMax
- Herbo Nutra
- NutraSci
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 292 |
| Published | August 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 975 million |
| Forecasted Market Value ( USD | $ 1707.5 million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
